
Richard Epstein on Property Rights and Drug Patents
EconTalk
00:00
Why pharma pays to speed FDA review
Epstein cites PDUFA fees as evidence firms prefer faster approvals, undermining anti-competitive regulatory motives.
Play episode from 56:44
Transcript


